Gary Milligan

2.1k total citations
72 papers, 1.5k citations indexed

About

Gary Milligan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Gary Milligan has authored 72 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 10 papers in Surgery. Recurrent topics in Gary Milligan's work include Advanced Breast Cancer Therapies (14 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Cancer-related Molecular Pathways (6 papers). Gary Milligan is often cited by papers focused on Advanced Breast Cancer Therapies (14 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and Cancer-related Molecular Pathways (6 papers). Gary Milligan collaborates with scholars based in United Kingdom, United States and Germany. Gary Milligan's co-authors include James Piercy, Victoria Higgins, Esther García Gil, M Benford, Tim Holbrook, S.M. Babineaux, B. Curtis, James Jackson, C. Molta and Gwyn W. Gould and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer Research.

In The Last Decade

Gary Milligan

68 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Milligan United Kingdom 18 398 296 232 207 189 72 1.5k
Susan D. Ross United States 21 348 0.9× 175 0.6× 115 0.5× 306 1.5× 159 0.8× 35 1.9k
Shmuel Tiosano Israel 24 232 0.6× 186 0.6× 236 1.0× 73 0.4× 454 2.4× 84 1.6k
Amy Mulick United Kingdom 21 546 1.4× 153 0.5× 96 0.4× 262 1.3× 62 0.3× 55 1.5k
Mihir Kamat United Kingdom 3 136 0.3× 324 1.1× 197 0.8× 100 0.5× 276 1.5× 3 2.2k
Carin Y. Smith United States 25 220 0.6× 92 0.3× 142 0.6× 397 1.9× 152 0.8× 68 2.4k
Markus Bredemeier Brazil 22 153 0.4× 131 0.4× 158 0.7× 69 0.3× 329 1.7× 54 1.3k
Fariborz Mobarrez Sweden 27 180 0.5× 170 0.6× 379 1.6× 125 0.6× 197 1.0× 79 1.9k
Claudia Specchia Italy 19 258 0.6× 291 1.0× 66 0.3× 242 1.2× 155 0.8× 50 1.7k
Roberto Ratiglia Italy 34 91 0.2× 331 1.1× 139 0.6× 200 1.0× 136 0.7× 102 3.6k
Harald Heidecke Germany 22 229 0.6× 118 0.4× 511 2.2× 73 0.4× 145 0.8× 88 2.2k

Countries citing papers authored by Gary Milligan

Since Specialization
Citations

This map shows the geographic impact of Gary Milligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Milligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Milligan more than expected).

Fields of papers citing papers by Gary Milligan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Milligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Milligan. The network helps show where Gary Milligan may publish in the future.

Co-authorship network of co-authors of Gary Milligan

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Milligan. A scholar is included among the top collaborators of Gary Milligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Milligan. Gary Milligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Al-Moamary, Mohamed, Bhumika Aggarwal, Mona Al‐Ahmad, et al.. (2025). Are Treatment Adherence Factors Apparent in Patients with Asthma and to Physicians? Results from the APPaRENT 3 Survey. Advances in Therapy. 42(3). 1506–1521. 1 indexed citations
2.
3.
Anstee, Quentin M., Kate Hallsworth, Niall Lynch, et al.. (2023). Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey. PubMed. Volume 14. 13–27. 2 indexed citations
4.
Armuzzi, Alessandro, Ailsa Hart, Joseph C. Cappelleri, et al.. (2023). Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five European countries. BMC Gastroenterology. 23(1). 17–17. 5 indexed citations
5.
6.
7.
8.
Haalen, Heleen van, et al.. (2020). Drug treatment patterns and work productivity in chronic kidney disease patients with anemia in China: Cross sectional analysis of real-world data. Kidney Research and Clinical Practice. 39(3). 318–333. 5 indexed citations
9.
10.
11.
Taylor‐Stokes, Gavin, et al.. (2020). 177P Real world treatment patterns and clinical outcomes associated with palbociclib combination therapy in Germany: Results from the IRIS study. Annals of Oncology. 31. S79–S80. 4 indexed citations
12.
Lipton, RB, Ravi Iyer, Joshua M. Cohen, et al.. (2019). PND102 BURDEN OF COMORBID DEPRESSION AND ANXIETY ON MIGRAINE-SPECIFIC HEALTH-RELATED QUALITY OF LIFE IN ADULT MIGRAINE PATIENTS IN THE UNITED STATES. Value in Health. 22. S756–S756. 1 indexed citations
13.
Mitra, Debanjali, et al.. (2018). Real world treatment patterns associated with palbociclib combination therapy in Germany: Results from the IRIS study. Annals of Oncology. 29. viii110–viii110. 2 indexed citations
14.
Tillett, William, et al.. (2018). The Economic Burden of Skin Symptoms in Psoriatic Arthritis. Value in Health. 21. S194–S194. 1 indexed citations
15.
16.
Graham, Anne, et al.. (2015). Symptoms, Concomitant Conditions And Cardiac Risk In European Hydroxyurea Treated Polycythemia Vera Patients. Value in Health. 18(7). A436–A436. 1 indexed citations
17.
Tremblay, Gabriel, Tim Holbrook, Gary Milligan, & Corey Pelletier. (2015). Matching-Adjusted Indirec Treatment Comparison And Survival Extrapolation In Radioiodine-Refractory Differentiated Thyroid Cancer (Rai-Refractory Dtc). Value in Health. 18(3). A11–A11. 1 indexed citations
18.
Chrystyn, Henry, et al.. (2013). Impact of patients' satisfaction with their inhalers on treatment compliance and health status in COPD. Respiratory Medicine. 108(2). 358–365. 114 indexed citations
19.
Tundia, Namita, Menaka Bhor, Amy Duhig, et al.. (2012). PMH58 Impact of Positive and Negative Symptoms and Cognitive Impairment on Health Outcomes and Healt Care Resource Utilization in European Patients with Schizophrenia. Value in Health. 15(4). A92–A92. 1 indexed citations
20.
Jess, Thomas J., et al.. (1993). Immunological Analysis of Glucose Transporters Expressed in Different Regions of the Rat Brain and Central Nervous System. Biochemical and Biophysical Research Communications. 192(3). 1297–1302. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan D. Ross Breakdown of academic impact, for papers by Shmuel Tiosano Breakdown of academic impact, for papers by Amy Mulick Breakdown of academic impact, for papers by Mihir Kamat Breakdown of academic impact, for papers by Carin Y. Smith Breakdown of academic impact, for papers by Markus Bredemeier Breakdown of academic impact, for papers by Fariborz Mobarrez Breakdown of academic impact, for papers by Claudia Specchia Breakdown of academic impact, for papers by Roberto Ratiglia Breakdown of academic impact, for papers by Harald Heidecke
Rankless by CCL
2026